NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 230 filers reported holding NEKTAR THERAPEUTICS in Q3 2022. The put-call ratio across all filers is 0.14 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $10,000 | -89.4% | 3,017 | -42.5% | 0.00% | -100.0% |
Q3 2021 | $94,000 | -65.4% | 5,248 | -66.9% | 0.00% | -66.7% |
Q2 2021 | $272,000 | +13500.0% | 15,849 | +11553.7% | 0.01% | – |
Q4 2020 | $2,000 | -99.6% | 136 | -99.4% | 0.00% | -100.0% |
Q2 2020 | $489,000 | +270.5% | 21,131 | +192.6% | 0.05% | +42.1% |
Q3 2019 | $132,000 | +1785.7% | 7,222 | +3212.8% | 0.04% | +1166.7% |
Q1 2019 | $7,000 | -30.0% | 218 | +36.2% | 0.00% | 0.0% |
Q3 2018 | $10,000 | -52.4% | 160 | -18.4% | 0.00% | -72.7% |
Q1 2018 | $21,000 | +200.0% | 196 | -51.0% | 0.01% | +175.0% |
Q3 2016 | $7,000 | – | 400 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ally Bridge Group (NY) LLC | 432,952 | $1,385,000 | 0.91% |
GREAT POINT PARTNERS LLC | 447,820 | $1,433,000 | 0.34% |
Birchview Capital, LP | 128,000 | $410,000 | 0.29% |
Edgestream Partners, L.P. | 1,047,636 | $3,352,000 | 0.26% |
Rhenman & Partners Asset Management AB | 550,000 | $2,068,000 | 0.22% |
CM Management, LLC | 50,000 | $160,000 | 0.18% |
TANG CAPITAL MANAGEMENT LLC | 430,037 | $1,376,000 | 0.17% |
PDT Partners, LLC | 307,953 | $985,000 | 0.15% |
Virtus ETF Advisers LLC | 72,018 | $230,000 | 0.09% |
ALGERT GLOBAL LLC | 476,412 | $1,525,000 | 0.09% |